Patents by Inventor Robert Lyndsay Sutherland

Robert Lyndsay Sutherland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel G protein-coupled receptor encoding gene and diagnostic uses therefor
    Publication number: 20030167485
    Abstract: The present invention provides GPR56 genes and polypeptides encoded therefor. The GPR56 genes of the invention are expressed highly in malignant tissues and the invention also provides diagnostic processes for detecting cancer or malignant tumors in human subjects The diagnostic and prognostic test of the present invention is particularly useful for the early detection of ovarian cancer or metastases thereof and for monitoring the progress of disease, such as, for example, during remission or following surgery or chemotherapy. The GPR56 gene of the invention is also expressed in effector memory T cells, and the invention therefor provides methods of identifying and/or quantifying effector memory T cells, which methods are useful for determining the immune status of a subject.
    Type: Application
    Filed: February 12, 2002
    Publication date: September 4, 2003
    Applicant: Garvan Institute of Medical Research
    Inventors: Herbert Herzog, Robert Lyndsay Sutherland, Charles R. MacKay, Susan Henshall
  • GDU, a novel signalling protein
    Publication number: 20030129639
    Abstract: The present invention provides the nucleotide and amino acid sequence of a previously unidentified erbB receptor target. The nucleotide and amino acid sequence is set out in the figure.
    Type: Application
    Filed: December 18, 2002
    Publication date: July 10, 2003
    Inventors: Roger John Daly, Robert Lyndsay Sutherland
  • GDU, a novel signalling protein
    Publication number: 20030044834
    Abstract: The present invention provides the nucleotide and amino acid sequence of a previously unidentified erbB receptor target. The nucleotide and amino acid sequence is set out in the figure.
    Type: Application
    Filed: September 11, 2002
    Publication date: March 6, 2003
    Inventors: Roger John Daly, Robert Lyndsay Sutherland